03 - 04 September, 2020
Hotel Palace Berlin, Germany
BenchSci uses artificial intelligence to optimize reagent procurement and experimental success. Backed by Google’s AI fund, Gradient Ventures, BenchSci uses machine learning to diagnose R&D health from hidden patterns in procurement data. Customers receive a report on failure rates, productivity, and redundancy by department, therapeutic area, geography, and cost center. They can then address inefficiencies by deploying BenchSci's AI-Assisted Reagent Selection, which empowers scientists to select the best reagents and design criteria for their experiments. Thereafter, post-deployment monitoring demonstrates impact and ROI. A turnkey application of AI with immediate, quantifiable impact, BenchSci now optimizes reagent procurement and experimental success in 15 of the top 20 pharmaceutical companies and over 3,600 leading academic centers globally.